|
Product Warning
Natural health product Libidfit may pose
health risks: Health Canada
January 26, 2006
Health Canada is warning consumers
not to use the natural health product Libidfit
because it has been found to contain an
undeclared ingredient that could lead to
serious health risks, especially for patients
with existing medical conditions such as
heart problems.
Libidfit is promoted for sexual enhancement
and erectile dysfunction, but contains
an undeclared amount of a pharmaceutical
ingredient similar to sildenafil, which
could pose a health risk when used without
medical supervision, especially in those
individuals who may be taking heart medications
or who have heart problems or are at risk
for strokes.
Sildenafil has also been associated with
serious side effects including sudden vision
loss, penile tissue damage and urinary
tract infection.
This product is not authorized for sale
in Canada, but it may be available to Canadian
consumers through personal importation,
the Internet or other venues. Canadians
who may have purchased Libidfit over the
Internet or while travelling abroad are
warned not to use it, and to consult with
a health care professional if they have
concerns about their health due to this
product.
Libidfit is manufactured by Libidfit
AG, and has been found for sale in Denmark
and on the Internet. As a result, the Danish
Medicines Agency issued a public warning
about the risks associated with Libidfit.
Health Canada also advises Canadians
to contact the Health Products and Food
Branch Inspectorate at 1-800-267-9675 if
they find Libidfit products in Canada.
Health Canada has notified the Canada Border
Services Agency to detain any shipment
of Libidfit at the border.
To date, no adverse reactions from the
use of this product has been reported in
Canada.
To report a suspected adverse reaction, health
professionals and consumers may contact the Canadian
Adverse Drug Reaction Monitoring Program (CADRMP)
of Health Canada by phone, toll free 1-866-234-2345,
by fax 1-866-678-6789 or via email at: cadrmp@hc-sc.gc.ca. |